Wockhardt, RDIF collaborate for producing Sputnik V, Sputnik Light
Mumbai: Wockhardt Limited, a global pharmaceutical company headquartered in India and the Russian Direct Investment Fund (RDIF), Russia's sovereign wealth fund have recently partnered to produce and supply Sputnik V and Sputnik Light vaccines against COVID-19.
The agreement was reached under the aegis of Enso Healthcare (part of Enso Group), RDIF's coordination partner for sourcing Sputnik V vaccines in India.
To date, the Sputnik V vaccine has been registered in 69 countries globally with a total population of over 3.7 billion people. The data obtained by regulators of a number of countries during the vaccination of the population, including Argentina, Serbia, Bahrain, Hungary, Mexico, San Marino, UAE and others, demonstrates that Sputnik V is one of the safest and most effective vaccines against coronavirus.
In particular, Sputnik V demonstrates 83.1% efficacy against the Delta variant of coronavirus - higher than many other vaccines. The vaccine shows 6 times reduction of infection risk. Sputnik V is also 94.4% effective against hospitalisations with 18 times reduction in hospitalisation risk. Sputnik V is based on a proven and well-studied platform of human adenoviral vectors and uses two different vectors for the two shots in a course of vaccination, providing immunity with a longer duration than vaccines using the same delivery mechanism for both shots. Sputnik Light is the first component of Sputnik V and is based on human adenovirus serotype 26.
Dr. Habil Khorakiwala, Founder Chairman of Wockhardt Group, said: "We are delighted to partner with RDIF to make a substantial contribution towards providing global supply of the Sputnik V and Sputnik Light vaccines which is one of the most efficacious approved vaccines commercially available. The arrangement upholds our ongoing commitment to fight against such a pandemic of global human importance."
Vinay Maloo, Chairman of Enso Healthcare, said: "It is our privilege to partner with RDIF and Wockhardt to facilitate large scale manufacturing of Sputnik V and Sputnik Light vaccines. Vaccinations are the most visible solution to this pandemic. We are proud to be a part of this noble cause. Sputnik V is known to have high efficacy and has emerged as a trusted vaccine."
Read also: RDIF proposes Pfizer conduct joint trials with Sputnik Light as booster shot
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.